Evidence map›Paper›PMID 26310823›Full record

ArticleNature communications2015

Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1.

Philipp Schneider, Juan Miguel Bayo-Fina, Rajeev Singh, Pavan Kumar Dhanyamraju, Philipp Holz, Aninja Baier, Volker Fendrich, Annette Ramaswamy, Stefan Baumeister, Elisabeth D Martinez and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Self-construction of actin networks through phase separation-induced abLIM1 condensates.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Philipp SchneiderDepartment of Medicine, Philipps University, Institute of Molecular Biology and Tumor Research (IMT), Center for Tumor Biology and Immunology, Hans-Meerwein-Street 3, 35043 Marburg, Germany.
Juan Miguel Bayo-FinaDepartment of Pharmacology, UT Southwestern Medical Center, 6000 Harry Hines boulevard, Dallas, Texas 75390-8593, USA.
Rajeev SinghDepartment of Medicine, Philipps University, Institute of Molecular Biology and Tumor Research (IMT), Center for Tumor Biology and Immunology, Hans-Meerwein-Street 3, 35043 Marburg, Germany.
Pavan Kumar DhanyamrajuDepartment of Medicine, Philipps University, Institute of Molecular Biology and Tumor Research (IMT), Center for Tumor Biology and Immunology, Hans-Meerwein-Street 3, 35043 Marburg, Germany.
Philipp HolzDepartment of Medicine, Philipps University, Institute of Molecular Biology and Tumor Research (IMT), Center for Tumor Biology and Immunology, Hans-Meerwein-Street 3, 35043 Marburg, Germany.
Aninja BaierDepartment of Surgery, Philipps University, Baldingerstraße 1, 35033 Marburg, Germany.
Volker FendrichDepartment of Surgery, Philipps University, Baldingerstraße 1, 35033 Marburg, Germany.
Annette RamaswamyDepartment of Pathology, Philipps University, Baldingerstraße 1, 35033 Marburg, Germany.
Stefan BaumeisterDepartment of Biology, Philipps University, Karl-von-Frisch-Straße 8, 35043 Marburg, Germany.
Elisabeth D MartinezDepartment of Pharmacology, UT Southwestern Medical Center, 6000 Harry Hines boulevard, Dallas, Texas 75390-8593, USA.
Matthias LauthDepartment of Medicine, Philipps University, Institute of Molecular Biology and Tumor Research (IMT), Center for Tumor Biology and Immunology, Hans-Meerwein-Street 3, 35043 Marburg, Germany.
Institute of Molecular Biology · DEPhilipps University of Marburg · DEThe University of Texas Southwestern Medical Center · US

Funding

Characterization of the biological activities of novel epigenetic modulatorsR01CA125269 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MARTINEZ, ELISABETH D · 2010 to 2014
$1.8M
NCI NIH HHS R01 CA125269
6 · The paper itself

Abstract

The Down syndrome-associated DYRK1A kinase has been reported as a stimulator of the developmentally important Hedgehog (Hh) pathway, but cells from Down syndrome patients paradoxically display reduced Hh signalling activity. Here we find that DYRK1A stimulates GLI transcription factor activity through phosphorylation of general nuclear localization clusters. In contrast, in vivo and in vitro experiments reveal that DYRK1A kinase can also function as an inhibitor of endogenous Hh signalling by negatively regulating ABLIM proteins, the actin cytoskeleton and the transcriptional co-activator MKL1 (MAL). As a final effector of the DYRK1A-ABLIM-actin-MKL1 sequence, we identify the MKL1 interactor Jumonji domain demethylase 1A (JMJD1A) as a novel Hh pathway component stabilizing the GLI1 protein in a demethylase-independent manner. Furthermore, a Jumonji-specific small-molecule antagonist represents a novel and powerful inhibitor of Hh signal transduction by inducing GLI1 protein degradation in vitro and in vivo.

Indexed as

Signal TransductionActin CytoskeletonActinsAnimalsCell Line, TumorDown SyndromeDyrk KinasesElectrophoresis, Polyacrylamide GelHedgehog ProteinsHumansImmunoblottingIn Vitro TechniquesJumonji Domain-Containing Histone DemethylasesKruppel-Like Transcription FactorsMiceMicrofilament ProteinsActinsDyrk KinasesGLI1 protein, humanGli1 protein, mouseHedgehog ProteinsJumonji Domain-Containing Histone DemethylasesKDM3A protein, humanKdm3a protein, mouseKruppel-Like Transcription FactorsMicrofilament ProteinsMRTFA protein, humanMrtfa protein, mouseProtein Serine-Threonine KinasesProtein-Tyrosine KinasesTrans-ActivatorsTranscription FactorsZinc Finger Protein GLI1

Identifiers

PMID26310823
PMCPMC4552080
OpenAlexW2257877211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.